Filter
372
Text search:
antiretrovirals
Featured
26
72
Language
Document type
242
48
47
21
5
4
3
1
1
Countries / Regions
16
15
14
13
11
10
10
9
9
7
7
6
6
6
6
6
5
5
5
4
4
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
168
32
15
9
8
3
3
Toolboxes
84
29
29
21
8
7
7
4
4
2
2
2
2
1
1
1
1
1
HIV Country Intelligence - HIV Country Profiles
HIV Country Intelligence - HIV Country Profiles
HIV Country Intelligence - HIV Country Profiles
HIV Country Intelligence - HIV Country Profiles
HIV Country Intelligence - HIV Country Profiles
HIV Country Intelligence - HIV Country Profiles
HIV Country Intelligence - HIV Country Profiles
HIV Country Intelligence - HIV Country Profiles
HIV Country Intelligence - HIV Country Profiles
HIV Country Intelligence - HIV Country Profiles
HIV Country Intelligence - HIV Country Profiles
HIV Country Intelligence - HIV Country Profiles
HIV Country Intelligence - HIV Country Profiles
HIV Country Intelligence - HIV Country Profiles
HIV Country Intelligence - HIV Country Profiles
Scoping Question: For adults and children living with HIV, which antiepileptic medications (such as phenobarbital, phenytoin, carbamazepine or valproic acid) produce benefits and/or harms when compared to a placebo or controls?
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination
Accessed: 08.10.2019
